Hong Kong, China

Yun Chung Leung

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Yun Chung Leung: Innovator in Amino Acid Depletion Therapy**

Introduction

Yun Chung Leung is a notable inventor based in Hong Kong, China, whose contributions to the field of biochemistry have garnered attention through his patent on amino acid depletion therapy. His innovative work aims to enhance cancer treatment methodologies, showcasing the potential of scientific advancements in medicine.

Latest Patents

Leung holds a patent titled "Compositions and methods for amino acid depletion therapy," which focuses on the preparation of high purity arginase and the efficient conjugation of this enzyme with polyethylene glycol. This patent details a method that includes a high-temperature precipitation step followed by ion exchange to achieve arginase purity of 90% or greater. The conjugated arginase exhibits effectiveness, particularly when used in combination with asparaginase, to inhibit the growth of cancer cells that express low levels of endogenous asparaginase.

Career Highlights

Leung is currently associated with Avalon Polytom (HK) Limited, where he applies his expertise in biochemistry to further develop therapeutic methods. His work emphasizes the importance of innovation in tackling complex medical challenges, especially in the area of oncology treatments.

Collaborations

Throughout his career, Yun Chung Leung has collaborated with talented colleagues such as Johnson Yiu-Nam Lau and Kuo-Ming Yu. Their combined efforts are pivotal in advancing research and practical applications in the field, and they contribute to a collaborative environment that fosters innovative solutions.

Conclusion

Yun Chung Leung represents a significant voice in the ongoing endeavor to improve cancer therapy through innovative biochemistry. His patent not only reflects his individual creativity and scientific rigor but also symbolizes the collective efforts of his team at Avalon Polytom (HK) Limited. As research in this area progresses, Leung's contributions are likely to play a crucial role in shaping the future of cancer treatment strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…